Product Recalls in Wyoming

Product recalls affecting Wyoming — including food, drugs, consumer products, medical devices, and vehicles distributed to Wyoming. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,367 recalls have been distributed to Wyoming in the last 12 months.

48,219 total recalls
2,367 in last 12 months

Showing 2346123480 of 48,219 recalls

DrugAugust 21, 2018· Auro Pharmacies, Inc.

Recalled Item: Testosterone Cypionate/Enanthate injectable Recalled by Auro Pharmacies,...

The Issue: Lack of Assurance of Sterility: Inadequate processes and equipment to assure...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 21, 2018· Auro Pharmacies, Inc.

Recalled Item: CoEnzyme-Q10 injectable Recalled by Auro Pharmacies, Inc. Due to Lack of...

The Issue: Lack of Assurance of Sterility: Inadequate processes and equipment to assure...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 20, 2018· Hetero Labs Limited Unit V

Recalled Item: Montelukast Sodium Tablets Recalled by Hetero Labs Limited Unit V Due to...

The Issue: Discoloration: A complaint was received from a pharmacist for the presence...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
Medical DeviceAugust 20, 2018· Varian Medical Systems

Recalled Item: TrueBeam Radiotherapy Delivery System version 2.0 and 2.5 EDGE Radiotherapy...

The Issue: Reports have been received of an anomaly that can result in a treatment...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
Medical DeviceAugust 20, 2018· Varian Medical Systems

Recalled Item: VitalBeam Radiotherapy Delivery System Version 2.5 Product Usage: The...

The Issue: Reports have been received of an anomaly that can result in a treatment...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
Medical DeviceAugust 17, 2018· COVIDIEN LLC

Recalled Item: EEA Circular Stapler with Tri-Staple Technology Recalled by COVIDIEN LLC Due...

The Issue: The firm identified the potential for a device to have an incorrect tissue...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine Recalled by Torrent Pharma Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine and Valsartan Tablets Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine and Valsartan Tablets Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine and Valsartan Tablets Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Valsartan Tablets USP Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine and Valsartan Tablets Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine Recalled by Torrent Pharma Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Valsartan Tablets USP Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine Recalled by Torrent Pharma Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Valsartan Tablets USP Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine Recalled by Torrent Pharma Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine Recalled by Torrent Pharma Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 15, 2018· Hetero Labs Limited Unit V

Recalled Item: Montelukast Sodium Tablets 10 mg Recalled by Hetero Labs Limited Unit V Due...

The Issue: Labeling: Label Mix-Up - One lot labeled Montelukast Sodium Tablets 10 mg...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
Medical DeviceAugust 15, 2018· Permobil, Ab

Recalled Item: Permobil powered wheelchairs Recalled by Permobil, Ab Due to This correction...

The Issue: This correction decision has been made because of a potential failure of one...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing